Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
_version_ | 1797107852437880832 |
---|---|
author | Coates, L O’Dwyer, J Meads, D Emery, P Conaghan, PG Helliwell, P |
author_facet | Coates, L O’Dwyer, J Meads, D Emery, P Conaghan, PG Helliwell, P |
author_sort | Coates, L |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T07:19:58Z |
format | Journal article |
id | oxford-uuid:87d9aec0-122f-480e-8aaa-6bf5e60152c4 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T07:19:58Z |
publishDate | 2022 |
publisher | Elsevier |
record_format | dspace |
spelling | oxford-uuid:87d9aec0-122f-480e-8aaa-6bf5e60152c42022-10-04T12:19:42ZTreat-to-target in psoriatic arthritis—cost-effective in the biosimilar eraJournal articlehttp://purl.org/coar/resource_type/c_1843uuid:87d9aec0-122f-480e-8aaa-6bf5e60152c4EnglishSymplectic ElementsElsevier2022Coates, LO’Dwyer, JMeads, DEmery, PConaghan, PGHelliwell, P |
spellingShingle | Coates, L O’Dwyer, J Meads, D Emery, P Conaghan, PG Helliwell, P Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era |
title | Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era |
title_full | Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era |
title_fullStr | Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era |
title_full_unstemmed | Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era |
title_short | Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era |
title_sort | treat to target in psoriatic arthritis cost effective in the biosimilar era |
work_keys_str_mv | AT coatesl treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera AT odwyerj treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera AT meadsd treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera AT emeryp treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera AT conaghanpg treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera AT helliwellp treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera |